CATHEPSINCYSTEINPROTEASEHEMMER

European patent · EP1817276 · Deleted

Register entry

Publication number
EP1817276
Application number
EP05808098
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 18, 2005
Published
Aug 15, 2007
Granted
Aug 8, 2012
Deleted
Jun 25, 2024
Reason
Annual fee unpaid
IPC classes
C07C 255/46 (2006.01)
A61K 31/275 (2006.01)
A61P 19/10 (2006.01)
Priority
US 630405 P 23.11.2004
PCT application
PCT/CA2005/001764 18.11.2005
PCT publication
WO2006/056047 01.06.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Deleted, fee unpaid

    Published in Swissreg on 25.06.2024

  2. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  3. Oct 16, 2012

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 16.10.2012

  4. Aug 8, 2012

    Granted

    Published in Swissreg on 08.08.2012

Parties

Holder

Merck Canada Inc.

16711 Trans-Canada Highway, Kirkland, QC H9H 3L1, CA

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

GAUTHIER, Jacques, Yves

Kirkland, Québec H9H 3L1, CA

LI, Chun, Sing

Kirkland, Québec H9H 3L1, CA

MELLON, Christophe

Kirkland, Québec H9H 3L1, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.